1. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study;Iuliano;Lancet,2018
2. The spectrum of influenza in children;Hoy;Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am.,2023
3. Recommendations for Prevention and Control of Influenza in Children, 2023–2024, Pediatrics 152(4) (2023).
4. Xofluza(baloxavir marboxil) tablets,for oral use Initial U.S. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210854Orig1s000ClinPharmR.pdf, (accessed 5 December 2022.).
5. Roche: European Commission Approves Xofluza For Children Aged One Year And Above. https://www.nasdaq.com/articles/roche:-european-commission-approves-xofluza-for-children-aged-one-year-and-above).